non-small cell lung cancer

Transgene to Move Lung Cancer Drug Into Advanced Tests
Bloomberg
Thu, 01/9/14 - 08:23 am
Transgene
TG-4010
non-small cell lung cancer
Karolinska's Axelar comes up short in Phase II with lung cancer drug
Fierce Biotech
Mon, 12/30/13 - 05:45 pm
Axelar
AXL1717
non-small cell lung cancer
Opportunities in Lung Cancer Therapies
Motley Fool
Sun, 11/24/13 - 12:30 pm
lung cancer
non-small cell lung cancer
Avastin
Genentech
Roche
Tarceva
AstraZeneca
Iressa
Alimta
selumetinib
Array Biopharma
CO-1686
Clovis Oncology
AP26113
Ariad Pharmaceuticals
Pfizer’s XALKORI® Granted Regular FDA Approval
Yahoo
Thu, 11/21/13 - 11:59 am
Pfizer
Xalkori
non-small cell lung cancer
OncoMed initiates second Phase 1b clinical trial of vantictumab
Yahoo/AP
Fri, 11/15/13 - 11:25 am
OncoMed
vantictumab
non-small cell lung cancer
Clovis, Synta, and Incyte Could Be Big Movers Today
Motley Fool
Tue, 10/29/13 - 09:42 am
Clovis Oncology
Synta
Incyte
CO-1686
non-small cell lung cancer
ganetespib
INCB39110
rheumatoid arthritis
Endocyte's Pipeline Encourages
Yahoo/Zacks
Wed, 10/16/13 - 09:24 am
Endocyte
vintafolide
ovarian cancer
non-small cell lung cancer
Data on ArQule's Tivantinib
Yahoo/Zacks
Sat, 10/5/13 - 09:18 am
Arqule
tivantinib
Daiichi Sankyo
lung cancer
non-small cell lung cancer
Roche's new round of lung cancer data keeps spotlight on immunotherapies
Fierce Biotech
Mon, 09/30/13 - 05:00 pm
Roche
PD-L1
non-small cell lung cancer
MPDL3280A
lung cancer
With Promising Results, AstraZeneca Targets Mutated Lung Cancer And Rival Clovis Drug
TheStreet.com
Mon, 09/30/13 - 10:31 am
AZD9291
Clovis Oncology
AstraZeneca
CO-1686
non-small cell lung cancer
ARIAD Presents Updated Phase 1/2 Data on AP26113 in Patients with Non-Small Cell Lung Cancer
Yahoo/BusinessWire
Sat, 09/28/13 - 11:57 am
non-small cell lung cancer
Ariad Pharmaceuticals
AP26113
Verastem Initiates Phase 2 Trial of Defactinib in Lung Cancer
Yahoo
Thu, 09/26/13 - 09:48 am
Defactinib
Verastem
non-small cell lung cancer
Infinity Pharma's cancer drug fails mid-stage trial goals
Reuters
Wed, 09/25/13 - 10:41 am
Infinity Pharma
non-small cell lung cancer
retaspimycin
Merck KGaA to continue testing cancer vaccine
Reuters
Wed, 09/25/13 - 08:44 am
vaccines
Merck KGaA
Stimuvax
Oncothyreon
non-small cell lung cancer
Eli Lilly Might Have A Blockbuster Cancer Drug
Seeking Alpha
Tue, 08/27/13 - 10:54 am
Eli Lilly
non-small cell lung cancer
necitumumab
Lilly set to begin critical Alimta patent dispute, WSJ says
The Fly on the Wall
Mon, 08/19/13 - 09:46 am
Eli Lilly
patents
Alimta
non-small cell lung cancer
Cancer Breakthrough Could Mean Big Gains for This Pharma Giant
Yahoo/Street Authority
Wed, 08/14/13 - 09:13 am
lung cancer
Eli Lilly
necitumumab
non-small cell lung cancer
Merck's Pipeline Of Drugs Should Make Up For Lost Sales To Generic Competition
Seeking Alpha
Mon, 08/12/13 - 09:11 am
Merck
generics
lambrolizumab
Odanacatib
melanoma
osteoporosis
non-small cell lung cancer
Ariad Pharma denied FDA's coveted 'breakthrough' stamp for lung cancer drug
Fierce Biotech
Fri, 08/9/13 - 10:00 am
Ariad Pharmaceuticals
FDA
non-small cell lung cancer
AP26113
FDA approves GILOTRIF™ (afatinib) as first-line treatment for metastatic non-small cell lung cancer with common EGFR mutations
Sacramento Bee, CA
Sat, 07/13/13 - 12:37 pm
non-small cell lung cancer
Gilotrif
Afatinib
Boehringer Ingelheim

Pages